Trials / Unknown
UnknownNCT04031651
Key Specialized Monitoring of Clinical Safety of Pudilan Xiaoyan Oral Liquid in the Real World
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 10,000 (estimated)
- Sponsor
- China Academy of Chinese Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To obtain the characteristics of adverse reactions/incidents, analyze the influencing factors and calculate the incidence of adverse reactions/incidents monitored by Pudilan Xiaoyan Oral Liquid in key specialties in the real world, so as to provide a basis for clinical safe and rational drug use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pudilan Xiaoyan Oral Liquid | In the respiratory and emergency departments of the hospitals under surveillance, the medication of Pudilan Xiaoyan Oral Liquid is observed for those aged 18-80 years who strictly follow the prescription of the instructions. |
Timeline
- Start date
- 2019-07-17
- Primary completion
- 2019-07-17
- Completion
- 2021-12-31
- First posted
- 2019-07-24
- Last updated
- 2019-07-24
Source: ClinicalTrials.gov record NCT04031651. Inclusion in this directory is not an endorsement.